Immunohematology Boot Camp: WAIHA (25EL-561)

Please note: AABB reserves the right to make updates to this program.

• Educational Track: Technical/Clinical
• Topics: Blood Donation & Collection, Patient Transfusion
• Intended Audience: Facilities that perform molecular testing, Hospital Blood Banks, Hospitals, Immunohematology Reference Labs (IRL’s), Laboratory Staff, Managers/Supervisors, Medical Directors, Nurses, Physicians, Residents/Fellows, Students (MD, MT, SBB), Technologists, Transfusion Safety Officers
• Teaching Level: Basic, Intermediate

• Director/Moderator: Hind Kurbaj, MS, SBB(ASCP)^CM, Program Director, Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX
  Speaker: Linda Song, MD, MSPH, Assistant Professor, Transfusion Medicine Physician, MD Anderson Cancer Center, Houston, TX

• Program Description

  This program will provide an overview of warm autoimmune hemolytic anemia (WAIHA), including clinical laboratory presentation and clinical management. The speaker will conclude with case-based reviews.

  Learning Objectives

  After participating in this educational activity, participants should be able to:

  • Discuss the pathogenesis and mechanism of red cell destruction and autoantibody production.
  • Differential between the various Autoimmune Hemolytic Anemia.
  • Explain the clinical assessment and laboratory tests of WAIHA.
  • Review treatment options and therapeutic approaches.

  Registration

  Please note: registration for the live eCast is now closed. Registration is available for the on-demand eCast. If you are registered for the live eCast you do not need to register for the on-demand eCast (access to the on-demand eCast was included with the live eCast registration).

  Single Viewer	Register
  Group Viewing	Register

  Continuing Education Credit

  This activity is eligible for one (1) continuing education credit/contact hour for Physicians, California Nurses, California Lab Personnel, Florida Lab Personnel and General Participation credit. AABB reserves the right to reduce or increase the number of credits granted based on the final activity duration. For more information on each credit type please visit our Continuing Education Credits webpage.

  There is no financial support for this activity.

  

  In support of improving patient care, this activity has been planned and implemented by the Association for the Advancement of Blood & Biotherapies (AABB), which is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

  Physicians (ACCME): AABB designates this live activity for a maximum of one (1) AMA PRA Category 1 Credit^TM. AABB designates this enduring activity for a maximum of one (1) AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  Claiming Credit
  Live Activity - Upon completion of the live activity, you will receive instructions to complete your evaluation, which is necessary to claim credit and receive your certificate of attendance/completion (credit must be claimed by the date provided in the instructions). The evaluation can be found by logging into the AABB Education Platform.

  Enduring Activity - Once the enduring (on-demand) program is available, you will receive instructions to access the AABB Education Platform. Upon completion of viewing the enduring activity, you will need to complete the evaluation, which is necessary to claim credit and receive your certificate of completion (credit must be claimed by the date provided in the AABB Education Platform).

  Program & Credit Expiration Dates:

  • Live Activity Program Date: August 6, 2025; Credit Expiration Date: September 6, 2025
  • Enduring Activity Program Dates: August 6, 2025 – August 5, 2028; Credit Expiration Date: August 5, 2028

  Disclosure Declaration

  It is the policy of the Association for the Advancement of Blood & Biotherapies to ensure independence, balance, objectivity, and scientific rigor and integrity in all of its CE activities. Faculty must disclose to the participants any relationships with commercial companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. AABB has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that the presence of such relationships will have a negative impact on the presentations.

  Disclosures for the planners of this event can be found here. Disclosures for the program faculty, peer reviewers, and AABB personnel are provided at the beginning of the program.

  Faculty Biography

  Hind Kurbaj received her master's in Immunohematology and Biotechnology from George Washington University. She currently works as the Program Director in Stem Cell Transplantation and Cellular Therapy at MD Anderson Cancer Center Transfusion Services in Houston, Texas.

  Dr. Linda Song is Assistant Professor at the University of Texas MD Anderson Cancer Center in the Department of Pathology and Laboratory Medicine. She board-certified in Transfusion Medicine after completing her Transfusion Medicine/Blood Bank fellowship at the National Institutes of Health in Bethesda, MD. Additionally, she completed her AP/CP residency training at University of Maryland Medical Center in Baltimore, MD. Her passions in transfusion medicine (and pathology in general) are pathology medical education of pathology and non-pathology providers as well as professional ambassadorship and systems/operations improvement.